9LFU
 
 | | Crystal structure of human RIP3 kinase domain complexed with LK01003 | | 分子名称: | 2-cyclopentyl-~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2025-01-09 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.93 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9LFW
 | | Crystal structure of mouse RIP3 kinase domain(R69H) complexed with LK01003 | | 分子名称: | 2-cyclopentyl-~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2025-01-09 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (1.59 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9LFV
 | | Crystal structure of mouse RIP3 kinase domain complexed with LK01004 | | 分子名称: | 3-[2-[(2~{R})-butan-2-yl]-1,3-benzothiazol-5-yl]-1-~{tert}-butyl-pyrazolo[3,4-d]pyrimidin-4-amine, 3-[2-[(2~{S})-butan-2-yl]-1,3-benzothiazol-5-yl]-1-~{tert}-butyl-pyrazolo[3,4-d]pyrimidin-4-amine, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2025-01-09 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.78 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IWY
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with LK01003 | | 分子名称: | 2-cyclopentyl-~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.52 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IX2
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with TAK-632 | | 分子名称: | N-{7-cyano-6-[4-fluoro-3-({[3-(trifluoromethyl)phenyl]acetyl}amino)phenoxy]-1,3-benzothiazol-2-yl}cyclopropanecarboxamide, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.39 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IWX
 | | Crystal structure of the mouse RIP3 kinase domain(R69H) in complexed with GSK'872 | | 分子名称: | Receptor-interacting serine/threonine-protein kinase 3, ~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (1.99 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IWW
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with GSK'872 | | 分子名称: | Receptor-interacting serine/threonine-protein kinase 3, ~{N}-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (1.93 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IWZ
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with GSK'843 | | 分子名称: | 3-(1,3-benzothiazol-5-yl)-7-(1,3-dimethyl-1H-pyrazol-5-yl)thieno[3,2-c]pyridin-4-amine, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (1.82 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IX1
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with PP2 | | 分子名称: | 1-TERT-BUTYL-3-(4-CHLORO-PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.31 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IX0
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with GW'39B | | 分子名称: | 4-methyl-3-[(7-pyridin-2-ylquinolin-4-yl)amino]phenol, Receptor-interacting serine/threonine-protein kinase 3 | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
9IX3
 | | Crystal structure of the mouse RIP3 kinase domain in complexed with compound 18 | | 分子名称: | Receptor-interacting serine/threonine-protein kinase 3, ~{N}-[4-[2-(cyclopropylcarbonylamino)pyridin-4-yl]oxy-2,3-dimethyl-phenyl]-1-(4-fluorophenyl)-2-oxidanylidene-pyridine-3-carboxamide | | 著者 | Xie, H, Su, H.X, Li, M.J, Xu, Y.C. | | 登録日 | 2024-07-26 | | 公開日 | 2025-05-07 | | 最終更新日 | 2025-05-21 | | 実験手法 | X-RAY DIFFRACTION (2.07 Å) | | 主引用文献 | Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.
Nat Commun, 16, 2025
|
|
